DC cell culture fluid and DC cell culture method

By using components such as GM-CSF and TNF-α in DC cell culture medium, the problem of low maturity of DC cells in the prior art was solved, efficient maturation of DC cells and T cell activation were achieved, and immune response was promoted .

CN118909939APending Publication Date: 2024-11-08东莞再立健生物科技有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411115783.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-14
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

In the existing DC cell culture methods, the prepared DC cells contain a large number of immature cells, have weak antigen presentation ability, and inhibit the proliferation of T cells.

Method used

DC cell culture medium containing GM-CSF, rhIL-4, TNF-α, LPS, IL-6, PGE2, FL-3t, TPO, phospholipids and inorganic salts was used to induce and promote DC at different stages through different components. Cell maturation and growth improve the maturity and immune activation ability of DC cells.

Benefits of technology

Effectively convert immature DC cells into mature DC cells, improve their antigen presentation ability and T cell activation ability, and promote the proliferation and immune response of T cells.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909939A_ABST
    Figure CN118909939A_ABST
Patent Text Reader

Abstract

The invention discloses a DC cell culture solution and a DC cell culture method. The DC cell culture solution comprises a lymphocyte serum-free culture medium, and the culture solution comprises a component A, a component B and a component C, wherein the component A is prepared from GM-CSF (Granulocyte Macrophage-Colony Stimulating Factor), rh I The component B comprises TNF (Tumor Necrosis Factor)-alpha, lipopolysaccharide, IL-6 and PGE2; the component C is prepared from FL-3t, TPO, phospholipid and inorganic salt. The DC cells are cultured to the seventh day, a component C containing FL-3t, TPO, phospholipid and inorganic salt is added into a cell culture solution, and through combined induction of the components, the maturity, amplification growth, migration ability and immune activation ability of the DC cells can be further improved, maturity of the DC cells is promoted, and high expression of the matured DC cells due to surface chemokine receptors is induced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of cell culture, and in particular to a DC cell culture solution and a DC cell culture method. Background Art

[0002] DC cells (Dendritic Cells) are widely distributed in the blood, liver, spleen, lymph nodes and other non-immune organs and tissues. They are the most powerful professional antigen presenting cells (APC) known to the body. They are also the only APC that can stimulate the initial T cell response and play a key role in the immune response. DC cells are closely related to the occurrence and development of tumors. They can efficiently absorb, process and present antigens. Immature DC cells have strong migration ability; mature DC cells can effectively activate initial T cells and are at the center of initiating, regulating, and maintaining immune responses. The core of an effective anti-tumor immune response is the production of CD8 + -T cells are the main cellular immune response, which is also the basis of DC cells as an immunotherapy; therefore, the more DC cells infiltrated in most solid tumors, the better the cure for the patients.

[0003] At present, the conventional in vitro DC cell preparation method is to use cytokines to induce, differentiate, and amplify DC cell precursor cells in peripheral blood or umbilical cord blood. Generally, the isolated mononuclear cells are first added to the DC cell serum-free culture medium, and then the appropriate amount of GM-CSF, IL-4 and other cytokines are added to culture the mononuclear cells into DC cells; then the corresponding tumor antigens are added and cultured to load the DC cells with tumor antigens. However, this conventionally prepared DC cell contains a large part of immature DC cells, that is, cell subsets with different degrees of maturity; this cell has a strong ability to absorb and process antigens, but a weak ability to present antigens, and poor ability to activate T cells, while also inhibiting the proliferation of T cells. Summary of the invention

[0004] Based on the above problems, the present invention provides a DC cell culture fluid and a DC cell culture method, so as to induce peripheral blood or umbilical cord blood to differentiate into cell subpopulations with different maturity levels and transform into mature DC cells, and effectively activate T cells in the human body and promote T cell proliferation and growth, so that T cells are at the central link of initiating, regulating, and maintaining immune responses.

[0005] The technical solution of the present invention is as follows:

[0006] The DC cell culture fluid provided by the present invention comprises a lymphocyte serum-free culture medium, wherein the culture fluid comprises component A, component B and component C; wherein:

[0007] Component A contains GM-CSF at a final concentration of 20-200 ng / ml, rhIL-4 at a final concentration of 20-100 ng / ml, and autologous serum at a final concentration of 1-10% (v / v);

[0008] Component B contains TNF-α at a final concentration of 5-20 ng / ml, lipopolysaccharide at a final concentration of 0.1-10 μg / ml, IL-6 at a final concentration of 50-200 ng / ml, and PGE2 at a final concentration of 1-200 μg / ml;

[0009] Component C contains FL-3t at a final concentration of 10-130 ng / ml, TPO at a final concentration of 1-80 ng / ml, phospholipids at a final concentration of 0.5-5 μg / ml, and inorganic salts at a final concentration of 1-10 mg / ml.

[0010] In the above DC cell culture medium, the lymphocyte serum-free culture medium is GT-T551H3, DMEM or RPMI-1640.

[0011] In the above DC cell culture medium, the phospholipid is phosphatidic acid or lysophosphatidic acid.

[0012] In the above DC cell culture medium, the inorganic salt includes one or more of sodium phosphate, potassium phosphate, calcium phosphate, magnesium phosphate, sodium chloride, potassium chloride, calcium chloride, magnesium chloride, sodium bicarbonate, potassium bicarbonate, calcium bicarbonate, and magnesium bicarbonate.

[0013] The present invention also provides a method for culturing DC cells using the above DC cell culture, comprising the following steps:

[0014] On day 0, first, mononuclear cells were added to a culture bottle containing the above-mentioned lymphocyte serum-free medium, and statically cultured in an incubator at 37° C. and 5% (v / v) CO2 for 2 h-5 h; then, the cell culture waste liquid and suspended cells in the culture bottle were removed, and the above-mentioned culture medium containing component A was supplemented, and static culture was performed in an incubator at 37° C. and 5% CO2;

[0015] On the third day, the cell culture waste liquid and suspended cells in the culture flask were removed, and the culture liquid containing component A was fully added to the culture flask, and static culture was carried out in an incubator at 37° C. and 5% (v / v) CO2;

[0016] On the fifth day, the cell culture waste liquid and suspended cells in the culture flask were removed, and the culture liquid containing component B was fully added to the culture flask, and static culture was carried out in an incubator at 37° C. and 5% (v / v) CO2;

[0017] On the 7th day, the cell culture waste liquid in the culture flask was removed, the cells in the culture flask were transferred to a culture bag, and the culture liquid containing the above-mentioned component C was fully added to the culture bag, and static culture was carried out in an incubator at 37° C. and 5% (v / v) CO2;

[0018] On day 9, the cell culture waste liquid was removed, the cells were collected and centrifuged at 300-800g for 5-10 min; the supernatant was removed, and the cell pellet was washed with PBS to obtain DC cells.

[0019] In the above DC cell culture method, when the culture medium containing component C is added on day 7, the pH value of the cell culture medium in the culture bag should be controlled at 7.2-7.6.

[0020] Compared with the prior art, the present invention has the following advantages:

[0021] 1. FL-3t in the C component of DC cell culture medium has the function of regulating and transforming immature DC cells into mature DC cells, while TPO in the C component has the function of stimulating and promoting the rapid maturation of DC cells;

[0022] 2. The phospholipids in the C component of the DC cell culture medium can effectively promote the growth of DC cells, while the inorganic salts, as the balanced salts in the cell culture medium, use their anionic and cationic ion buffering effects to maintain the pH range required by cell physiology, maintain the intracellular and extracellular osmotic pressure during cell growth, and ensure rapid cell growth;

[0023] 3. In the DC cell culture method, adding culture medium containing component C from the 7th day is beneficial to further transform DC cells of different maturity into mature DC cells and achieve rapid proliferation and growth; at the same time, it effectively activates T cells in the human body and promotes T cell proliferation and growth, making T cells the central link in initiating, regulating, and maintaining immune responses. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 This is a flow chart of the DC cell culture process of the present invention;

[0025] Figure 2 The DC cells in Examples 1 to 4 were cultured on the 9th day, and the DCs were observed under an optical microscope at a magnification of 40 times; wherein, Picture a is a picture of the DC cells in Example 1, Picture b is a picture of the DC cells in Example 2, Picture c is a picture of the DC cells in Example 3, and Picture d is a picture of the DC cells in Example 4;

[0026] Figure 3The figure is a flow cytometric detection diagram of the DC cell markers CD11c and CD86 phenotypes on the 9th day of DC cell culture in Example 1; wherein, Figure a is a flow cytometric diagram of the DC precursor cell CD14 phenotype in Example 1, and Figure b is a flow cytometric diagram of the mature DC cell CD11c and CD86 phenotypes in Example 1;

[0027] Figure 4 The figure is a flow cytometric detection diagram of the DC cell markers CD11c and CD86 phenotypes on the 9th day of DC cell culture in Example 2; wherein, Figure a is a flow cytometric diagram of the DC precursor cell CD14 phenotype in Example 2, and Figure b is a flow cytometric diagram of the mature DC cell CD11c and CD86 phenotypes in Example 2;

[0028] Figure 5 The figure is a flow cytometric detection diagram of the DC cell markers CD11c and CD86 phenotypes on the 9th day of DC cell culture in Example 3; wherein, Figure a is a flow cytometric diagram of the DC precursor cell CD14 phenotype in Example 3, and Figure b is a flow cytometric diagram of the mature DC cell CD11c and CD86 phenotypes in Example 3;

[0029] Figure 6 The figure is a flow cytometric detection diagram of the DC cell markers CD11c and CD86 phenotypes on the 9th day of DC cell culture in Example 4; wherein, Figure a is a flow cytometric diagram of the DC precursor cell CD14 phenotype in Example 4, and Figure b is a flow cytometric diagram of the mature DC cell CD11c and CD86 phenotypes in Example 4;

[0030] Figure 7 This is a growth curve of DC cell culture expansion in Examples 1 to 4. DETAILED DESCRIPTION

[0031] The preferred embodiments of the present invention are further described in detail below in conjunction with the accompanying drawings.

[0032] DC is mainly obtained by directional induction, differentiation and expansion of DC precursor cells from bone marrow, peripheral blood and umbilical cord blood using cytokines. The collection of bone marrow and umbilical cord blood is inconvenient, and large-scale application is limited. Peripheral blood is currently a better way to obtain DC because it is easy to obtain, does not require complex screening and purification processes, and uses fewer cytokine combinations. However, since the differentiation and development of DC is completed in an environment of cytokine combinations, DC precursor cells can differentiate into cell subpopulations with different degrees of maturity in different microenvironments, different cell stimulation factors and different induced differentiation pathways; this cell subpopulation contains a small number of mature DC cells, a large number of immature DC cells and some undifferentiated mononuclear cells.

[0033] Therefore, the present invention, on the basis of conventional DC cell culture medium, adds DC cell inducing components and expansion growth components, so that the cell subpopulations with different maturity obtained by culture and differentiation are converted into mature DC cells and the rapid expansion and growth of mature DC cells are promoted, and the T cells in the human body are effectively activated, so that they are at the central link of initiating, regulating, and maintaining the immune response.

[0034] In the preparation of DC cell culture fluid, in addition to using conventional components such as GM-CSF (cytokines including recombinant human granulocyte-macrophage colony stimulating factor), rhIL-4 (recombinant human interleukin 4), TNF-α (recombinant human tumor necrosis factor-α), LPS (lipopolysaccharide), IL-6 (interleukin-6) and PGE2 (prostaglandin E2), the DC cell culture fluid of the present invention also adds components such as FL-3t (cytokine of FL 3 ligand), TPO (recombinant human TPO (thrombopoietin)), phospholipids and inorganic salts.

[0035] In the DC cell culture medium, each component plays an important role in the induction and differentiation of mononuclear cells into DC cells, as well as in the maturation and growth of DC cells, as follows.

[0036] GM-CSF is a hematopoietic growth factor that promotes the differentiation of mononuclear cells into macrophage-like cells during DC cell culture and increases the expression of MHC class II molecules on the cell surface, thereby enhancing the antigen presentation function of the cells and promoting the survival of DC cells.

[0037] During the culture of DC, IL-4 can inhibit the excessive growth of macrophages, thereby guiding the differentiation of mononuclear cells into DC cells; at the same time, it reduces the expression of CD14 molecules on the cell surface. The reduction of CD14 expression level is an important sign of the differentiation of mononuclear cells into DC cells. The combined effect of IL-4 and GM-CSF can direct the differentiation of mononuclear cells into immature DCs. At this time, DCs have strong antigen uptake and processing capabilities, but weak antigen presentation capabilities.

[0038] TNF-α can stimulate target cells, induce MHC antigens, down-regulate the macropinocytosis of immature DCs and the expression of surface Fc receptors, cause the disappearance of intracellular MHC class II molecule compartments, up-regulate the expression of cell surface MHC class I, class II molecules and B7 family molecules, cause immature DCs to differentiate into mature DCs, significantly weaken the antigen uptake and processing ability of DCs, and significantly enhance the antigen presentation ability, thereby activating T cells and playing an important role in immune regulation and anti-tumor defense mechanisms.

[0039] LPS can stimulate DC cell maturation in the short term, promote DC cells to produce cytokines, and also has an immune activation effect, can activate immune cells, and has a wide range of biological activities.

[0040] IL-6 is an important proinflammatory cytokine that can recruit mononuclear cells, inhibit regulatory T (Treg) cell differentiation and T cell apoptosis, and promote inflammatory responses.

[0041] PGE2 can increase the production, maturity, migration ability and immune activation ability of DCs, promote the maturation of DCs, induce high expression of surface chemokine receptors of mature DCs, inhibit the antigen uptake function of DCs, promote the proliferation of T cells, and thus induce an immune response against tumors.

[0042] FL-3t has the function of regulating and transforming immature DC cells into mature DC cells, while TPO has the function of stimulating and promoting the rapid maturation of DC cells; phospholipids can effectively promote the growth of DC cells, and inorganic salts, as the balancing salts in the cell culture medium, utilize their anion and cation ion buffering effect to maintain the pH range required for cell physiology, maintain the intracellular and extracellular osmotic pressure during cell growth, and ensure rapid cell growth.

[0043] Therefore, in the DC cell culture process of the present invention, GM-CSF and IL-4 are added to culture mononuclear cells to induce the mononuclear cells to differentiate into DCs, and immature DC cells are obtained; at this time, the DC cells have strong antigen uptake and processing capabilities, but weak antigen presentation capabilities, and then TNF-α, LPS, IL-6 and PGE2 are added to preliminarily induce DC cell maturation to obtain partially mature DC cells, at which time the antigen uptake and processing capabilities of DC are relatively weakened, but the antigen presentation capability is significantly enhanced; subsequently, FL-3t, TPO, phospholipids and inorganic salts are combined to induce, which can further improve the yield, maturity, migration ability and immune activation ability of DC cells, promote DC cell maturation, induce mature DC to have high expression of surface chemokine receptors, inhibit the antigen uptake function of DC cells, promote the proliferation of T cells, activate T cells, and cause immune response.

[0044] like Figure 1 As shown, specifically, the DC cell culture process steps of the present invention are as follows:

[0045] S1. Prepare DC cell culture medium: Using lymphocyte serum-free culture medium as base medium, prepare component A, component B and component C respectively; wherein:

[0046] Component A: The culture medium contains GM-CSF at a final concentration of 20-200 ng / ml, rhIL-4 at a final concentration of 20-100 ng / ml, and autologous serum at a final concentration of 1-10% (v / v);

[0047] Component B: The culture medium contains TNF-α at a final concentration of 5-20 ng / ml, lipopolysaccharide at a final concentration of 0.1-10 μg / ml, IL-6 at a final concentration of 50-200 ng / ml, and PGE2 at a final concentration of 1-200 μg / ml;

[0048] Component C: The culture medium contains FL-3t at a final concentration of 10-130 ng / ml, TPO at a final concentration of 1-80 ng / ml, phospholipids at a final concentration of 0.5-5 μg / ml, and inorganic salts at a final concentration of 1-10 mg / ml;

[0049] S2, mononuclear cells were obtained from peripheral blood (PBMC) or umbilical cord blood;

[0050] S3. On day 0, first, the mononuclear cells are added to a culture bottle containing 100 ml of lymphocyte serum-free culture medium, and statically cultured in an incubator at 37° C. and 5% (v / v) CO2 for 2 h-5 h to allow the mononuclear cells to adhere to the wall; then, the cell culture waste liquid and suspended cells in the culture bottle are removed, and 400 ml of the culture solution containing component A prepared in step S1 is added, and static culture is continued in an incubator at 37° C. and 5% CO2 to induce the mononuclear cells to differentiate into DC cells;

[0051] S4. On the third day, the cell culture waste liquid and suspended cells in the culture flask were removed, and 500 ml of the culture solution containing component A prepared in step S1 was added to the culture flask, and the flask was cultured in an incubator at 37° C. and 5% (v / v) CO2 to continue inducing the mononuclear cells to differentiate into DC cells;

[0052] S5. On the 5th day, the cell culture waste liquid and suspended cells in the culture flask were removed, and 500 ml of the culture solution containing component B prepared in step S1 was added to the culture flask, and the cells were cultured statically in an incubator at 37° C. and 5% (v / v) CO2 to induce further differentiation into mature DC cells and obtain cell subpopulations with different degrees of maturity;

[0053] S6. On the 7th day, the cell culture waste liquid and suspended cells in the culture flask are removed, the cells in the culture flask are transferred to a culture bag, and 500 ml of the culture solution containing component C prepared in step S1 is added to the culture bag, and the bag is statically cultured in an incubator at 37° C. and 5% (v / v) CO2 to promote the transformation of cell subpopulations with different maturities into mature DC cells and promote the rapid proliferation and growth of mature DC cells;

[0054] S7. On the 9th day, the cell culture waste liquid was removed, the cells were collected and centrifuged at 300-800g for 5-10 min; the supernatant was removed, and the cell pellet was washed with PBS to obtain DC cells;

[0055] S8. Resuspend DC cells with freezing solution, divide the cell suspension into 10 ml cryotubes, freeze in liquid nitrogen and set aside.

[0056] In the above DC cell culture step S1, a lymphocyte serum-free culture medium is used as a base liquid to prepare component A, component B and component C respectively; wherein:

[0057] Component A: The culture medium contains GM-CSF at a final concentration of 20-100 ng / ml, rhIL-4 at a final concentration of 10-60 ng / ml, and autologous serum at a final concentration of 2-7% (v / v);

[0058] Component B: The culture medium contains TNF-α at a final concentration of 8-15 ng / ml, lipopolysaccharide at a final concentration of 1-6 μg / ml, IL-6 at a final concentration of 80-160 ng / ml, and PGE2 at a final concentration of 10-80 μg / ml;

[0059] Component C: The culture medium contains FL-3t at a final concentration of 20-90 ng / ml, TPO at a final concentration of 10-70 ng / ml, phospholipids at a final concentration of 0.1-3 μg / ml, and inorganic salts at a final concentration of 2-7 mg / ml.

[0060] In addition, in the above-mentioned DC cell culture step S1, the lymphocyte serum-free medium can be any one of GT-T551H3, DMEM or RPMI-1640. The phospholipid is preferably phosphatidic acid or lysophosphatidic acid. The inorganic salt includes one or more of sodium phosphate, potassium phosphate, calcium phosphate, magnesium phosphate, sodium chloride, potassium chloride, calcium chloride, magnesium chloride, sodium bicarbonate, potassium bicarbonate, calcium bicarbonate, and magnesium bicarbonate.

[0061] Inorganic salt solution is used as a balanced salt solution. Its anions, cations and ion buffer pairs are used to maintain the pH range required for cell physiology. The four main cations in physiological solutions are Na + , K + , Ca 2+ Mg 2+ etc., are important for maintaining cell membrane potential and nutrient transport, and cation Na + and K + It plays a key role in determining the osmotic pressure inside and outside the cell membrane and maintaining osmotic balance, and prevents damage to the cell growth process; the anion PO4 in the inorganic salt solution 3- , Cl - and HCO3 - etc., to maintain the optimal pH value of 7.2-7.6 for cells.

[0062] If the inorganic salt is bicarbonate, such as sodium bicarbonate, potassium bicarbonate, calcium bicarbonate, magnesium bicarbonate, etc., then on the 7th day, the culture environment in the incubator should be 36°C, 6% (v / v) CO2; this culture environment can achieve a pH value that is conducive to the growth of DC cells.

[0063] In the above-mentioned DC cell culture step S2, mononuclear cells are obtained from peripheral blood (PBMC) or umbilical cord blood, and mononuclear cells can also be obtained from bone marrow. Peripheral blood is easy to obtain, does not require complex screening and purification processes, and uses fewer cytokine combinations. Therefore, in the present invention, peripheral blood is preferred and blood gradient centrifugation is used to obtain mononuclear cells. These processes belong to the prior art and will not be repeated here.

[0064] In the above DC cell culture step S7, when the culture medium containing component C is added on the 7th day, the pH value of the cell culture medium in the culture bag should be controlled at 7.2-7.6, which is conducive to the growth of DC cells.

[0065] The technical solution of the present invention is further described in detail below through specific embodiments (including comparative examples).

[0066] In the following examples (including comparative examples), the number of mononuclear cells is 1×10 6 indivual.

[0067] 1. DC cell culture

[0068] Example 1

[0069] 1.1. Prepare DC cell culture medium: Using GT-T551H3 serum-free culture medium as the base medium, prepare component A, component B and component C respectively; wherein:

[0070] Component A 1000 ml: in GT-T551H3, contains GM-CSF at a final concentration of 50 ng / ml, rhIL-4 at a final concentration of 50 ng / ml, and autologous serum at a final concentration of 5% (v / v);

[0071] Component B 1000 ml: in GT-T551H3, containing TNF-α at a final concentration of 10 ng / ml, LPS at a final concentration of 5 μg / ml, IL-6 at a final concentration of 100 ng / ml, and PGE2 at a final concentration of 100 μg / ml;

[0072] Component C 1000 ml: in GT-T551H3, contains FL-3t at a final concentration of 50 ng / ml, TPO at a final concentration of 20 ng / ml, phosphatidic acid at a final concentration of 2 μg / ml, and sodium phosphate at a final concentration of 3 mg / ml;

[0073] 1.2. On day 0, first, 1×10 6The mononuclear cells were added to a T75 culture flask containing 100 ml of GT-T551H3 culture medium, and cultured in a 37°C, 5% (v / v) CO2 incubator for 3 hours to allow the mononuclear cells to adhere to the wall; then, the cell culture waste liquid and suspended cells in the T75 culture flask were discarded, and 400 ml of culture medium containing component A was added, and the culture was continued in a 37°C, 5% CO2 incubator to induce the mononuclear cells to differentiate into DC cells;

[0074] 1.3. On the third day, discard the cell culture waste liquid and part of the suspended cells in the T75 culture flask as much as possible, replace the full volume of the medium in the T75 culture flask with 500 ml of culture medium containing component A, and culture it in an incubator at 37°C and 5% (v / v) CO2 to continue inducing the mononuclear cells to differentiate into DC cells;

[0075] 1.4. On the 5th day, discard the cell culture waste liquid and suspended cells in the T75 culture flask as much as possible, replace the full volume of the medium in the T75 culture flask with 500 ml of culture medium containing component B, and culture it statically in an incubator at 37°C and 5% (v / v) CO2 to induce further differentiation into mature DC cells and obtain cell subsets with different degrees of maturity;

[0076] 1.5. On the 7th day, discard the cell culture waste liquid and suspended cells in the T75 culture flask, transfer the cells in the T75 culture flask to the culture bag, and add 500 ml of culture medium containing component C to the culture bag. The pH value of the cell culture medium in the culture bag should be controlled at 7.4, and the culture is statically cultured in an incubator at 37°C and 5% (v / v) CO2 to promote the transformation of cell subpopulations with different maturity into mature DC cells and promote the rapid expansion and growth of mature DC cells;

[0077] 1.6. On day 9, the cell culture wastewater was removed, the cell pellet was collected and centrifuged at 500 g for 8 min; the supernatant was removed, and the cell pellet was washed twice with PBS to obtain mature DC cells;

[0078] 1.7. Resuspend DC cells with freezing solution and divide the cell suspension into 10 ml cryotubes. Freeze in liquid nitrogen for later use.

[0079] Example 2

[0080] 2.1. Preparation of DC cell culture medium: Using DMEM serum-free medium as the base medium, prepare component A, component B and component C respectively; wherein:

[0081] Component A 1000 ml: in DMEM, containing GM-CSF at a final concentration of 20 ng / ml, rhIL-4 at a final concentration of 100 ng / ml, and autologous serum at a final concentration of 1% (v / v);

[0082] Component B 1000 ml: in DMEM, containing TNF-α at a final concentration of 5 ng / ml, LPS at a final concentration of 0.1 μg / ml, IL-6 at a final concentration of 200 ng / ml, and PGE2 at a final concentration of 1 μg / ml;

[0083] Component C 1000 ml: in DMEM, containing FL-3t at a final concentration of 10 ng / ml, TPO at a final concentration of 80 ng / ml, lysophosphatidic acid at a final concentration of 0.5 μg / ml, and magnesium chloride at a final concentration of 1 mg / ml;

[0084] 2.2. On day 0, first, 1×10 6 The mononuclear cells were added to a T75 culture flask containing 100 ml of DMEM medium, and cultured in a 37°C, 5% CO2 (v / v) incubator for 2 h to allow the mononuclear cells to adhere to the wall; then, the cell culture waste liquid and suspended cells in the T75 culture flask were discarded, and 400 ml of culture medium containing component A was added, and the culture was continued in a 37°C, 5% CO2 incubator to induce the mononuclear cells to differentiate into DC cells;

[0085] 2.3. On the third day, discard the cell culture waste liquid and part of the suspended cells in the T75 culture flask as much as possible, replace the full volume of the medium in the T75 culture flask with 500 ml of culture medium containing component A, and culture it in a 37°C, 5% (v / v) CO2 incubator to continue inducing the mononuclear cells to differentiate into DC cells;

[0086] 2.4. On the 5th day, discard the cell culture waste liquid and suspended cells in the T75 culture flask as much as possible, replace the medium in the T75 culture flask with 500 ml of culture medium containing component B, and culture it in an incubator at 37°C and 5% (v / v) CO2 to induce further differentiation into mature DC cells and obtain cell subsets with different degrees of maturity;

[0087] 2.5. On the 7th day, discard the cell culture waste liquid and suspended cells in the T75 culture flask, transfer the cells in the T75 culture flask to the culture bag, and add 500 ml of culture medium containing component C to the culture bag. The pH value of the cell culture medium in the culture bag should be controlled at 7.2, and the culture is statically cultured in an incubator at 37°C and 5% (v / v) CO2 to promote the transformation of cell subpopulations with different maturity into mature DC cells and promote the rapid expansion and growth of mature DC cells;

[0088] 2.6. On day 9, the cell culture wastewater was removed, the cell pellet was collected and centrifuged at 800 g for 5 min; the supernatant was removed, and the cell pellet was washed twice with PBS to obtain mature DC cells;

[0089] 2.7. Resuspend DC cells with freezing solution and divide the cell suspension into 10 ml cryotubes. Freeze in liquid nitrogen for later use.

[0090] Example 3

[0091] 3.1. Preparation of DC cell culture medium: Using RPMI-1640 serum-free culture medium as the base medium, prepare component A, component B and component C respectively; wherein:

[0092] Component A 1000 ml: in RPMI-1640, containing GM-CSF at a final concentration of 200 ng / ml, rhIL-4 at a final concentration of 20 ng / ml, and autologous serum at a final concentration of 10% (v / v);

[0093] Component B 1000 ml: in RPMI-1640, containing TNF-α at a final concentration of 20 ng / ml, LPS at a final concentration of 10 μg / ml, IL-6 at a final concentration of 50 ng / ml, and PGE2 at a final concentration of 200 μg / ml;

[0094] Component C 1000 ml: in RPMI-1640, containing FL-3t at a final concentration of 130 ng / ml, TPO at a final concentration of 1 ng / ml, phosphatidic acid at a final concentration of 5 μg / ml, and potassium bicarbonate at a final concentration of 10 mg / ml;

[0095] 3.2. On day 0, first, 1×10 6 Add 100 ml of RPMI-1640 medium to a T75 culture flask, and culture it in a 37°C, 5% (v / v) CO2 incubator for 5 h to allow the mononuclear cells to adhere to the wall; then, discard the cell culture waste liquid and suspended cells in the T75 culture flask, add 400 ml of culture medium containing component A, and continue to culture it in a 37°C, 5% CO2 incubator to induce the mononuclear cells to differentiate into DC cells;

[0096] 3.3. On the third day, discard the cell culture waste liquid and part of the suspended cells in the T75 culture flask as much as possible, replace the medium in the T75 culture flask with 500 ml of culture medium containing component A, and culture it in an incubator at 37°C and 5% (v / v) CO2 to continue inducing the mononuclear cells to differentiate into DC cells;

[0097] 3.4. On the 5th day, discard the cell culture waste liquid and suspended cells in the T75 culture flask as much as possible, replace the medium in the T75 culture flask with 500 ml of culture medium containing component B, and culture it in an incubator at 37°C and 5% (v / v) CO2 to induce further differentiation into mature DC cells and obtain cell subsets with different degrees of maturity;

[0098] 3.5. On the 7th day, discard the cell culture waste liquid and suspended cells in the T75 culture flask, transfer the cells in the T75 culture flask to the culture bag, and add 500 ml of culture medium containing component C to the culture bag. The pH value of the cell culture medium in the culture bag should be controlled at 7.6, and the culture was statically cultured in an incubator at 36°C and 6% (v / v) CO2 to promote the transformation of cell subpopulations with different maturity into mature DC cells and promote the rapid expansion and growth of mature DC cells;

[0099] 3.6. On day 9, the cell culture wastewater was removed, the cell pellet was collected and centrifuged at 300 g for 10 min; the supernatant was removed, and the cell pellet was washed twice with PBS to obtain mature DC cells;

[0100] 3.7. Resuspend DC cells with freezing solution and divide the cell suspension into 10 ml cryotubes. Freeze in liquid nitrogen for later use.

[0101] Example 4 (Comparative Example 1)

[0102] This example is a comparative example, in which the DC cell culture medium is a conventional culture medium containing only components A and B; when the DC cells are cultured to the 7th day, the culture medium supplemented with the culture medium containing component B is used.

[0103] 4.1. Preparation of DC cell culture medium: Using GT-T551H3 serum-free culture medium as the base medium, prepare component A and component B respectively; wherein:

[0104] Component A 1000 ml: in GT-T551H3, contains GM-CSF at a final concentration of 70 ng / ml, rhIL-4 at a final concentration of 40 ng / ml, and autologous serum at a final concentration of 4% (v / v);

[0105] Component B 1000 ml: in GT-T551H3, containing TNF-α at a final concentration of 55 ng / ml, LPS at a final concentration of 2 μg / ml, IL-6 at a final concentration of 120 ng / ml, and PGE2 at a final concentration of 80 μg / ml;

[0106] 4.2. On day 0, first, 1×10 6 The mononuclear cells were added to a T75 culture flask containing 100 ml of GT-T551H3 culture medium, and cultured in a 37°C, 5% (v / v) CO2 incubator for 3 hours to allow the mononuclear cells to adhere to the wall; then, the cell culture waste liquid and suspended cells in the T75 culture flask were discarded, and 400 ml of culture medium containing component A was added, and the culture was continued in a 37°C, 5% CO2 incubator to induce the mononuclear cells to differentiate into DC cells;

[0107] 4.3. On the third day, discard the cell culture waste liquid and part of the suspended cells in the T75 culture flask as much as possible, replace the medium in the T75 culture flask with 500 ml of culture medium containing component A, and culture it in a 37°C, 5% (v / v) CO2 incubator to continue inducing the mononuclear cells to differentiate into DC cells;

[0108] 4.4. On the 5th day, discard the cell culture waste liquid and suspended cells in the T75 culture flask as much as possible, replace the medium in the T75 culture flask with 500 ml of culture medium containing component B, and culture it in an incubator at 37°C and 5% (v / v) CO2 to induce further differentiation into mature DC cells and obtain cell subsets with different degrees of maturity;

[0109] 4.5. On the 7th day, discard the cell culture waste liquid and suspended cells in the T75 culture flask, transfer the cells in the T75 culture flask to the culture bag, and add 500 ml of culture medium containing component B to the culture bag. The pH value of the cell culture medium in the culture bag should be controlled at 7.4, and the culture is statically cultured in an incubator at 37°C and 5% (v / v) CO2 to promote the transformation of cell subpopulations with different maturity into mature DC cells and promote the rapid proliferation and growth of mature DC cells;

[0110] 4.6. On day 9, the cell culture wastewater was removed, the cell pellet was collected and centrifuged at 500 g for 8 min; the supernatant was removed, and the cell pellet was washed twice with PBS to obtain mature DC cells;

[0111] 4.7. Resuspend DC cells with freezing solution and divide the cell suspension into 10 ml cryotubes. Freeze in liquid nitrogen for later use.

[0112] 2. DC cell functional detection test

[0113] 1. Observation of DC cell morphology

[0114] Take the DC cells in Examples 1 to 4, sample them on the 9th day of culture, and observe the DC cells under an optical microscope at 40 times magnification. The microscopic photos are as follows: Figure 2 As shown; wherein, picture a is a photo of DC cells in Example 1, picture b is a photo of DC cells in Example 2, picture c is a photo of DC cells in Example 3, and picture d is a photo of DC cells in Example 4.

[0115] from Figure 2 It can be observed in the photos shown that after the 9th day of the mononuclear cell induction culture of DC cells, mature DC cells, i.e., dendritic cells, with stellate polymorphism or dendrites on the outer wall of the cells can be seen in Examples 1 to 4. It can be seen that in Examples 1 to 4, after the mononuclear cells were induced to differentiate and cultured using conventional DC culture medium or the DC culture medium provided by the present invention, mature DC cells can be obtained.

[0116] 2. DC cell flow cytometry phenotyping

[0117] Take the DC cells in Examples 1 to 4, sample them on the 9th day of culture, add PBS solution, and adjust the cell concentration to 1×10 6 / ml. Using flow cytometry, the DC precursor cell (i.e., immature DC cell) marker CD14, DC cell marker CD11c and CD86 were detected by phenotypic flow cytometry. The flow cytometry detection diagram is shown in the figure. Figures 3 to 6 shown.

[0118] Figure 3 In the figure, picture a is the flow cytometric graph of CD14 phenotype of DC precursor cells in Example 1, and picture b is the flow cytometric graph of CD11c and CD86 phenotype of DC cells in Example 1;

[0119] Figure 4 In the figure, picture a is the flow cytometric graph of the CD14 phenotype of DC precursor cells in Example 2, and picture b is the flow cytometric graph of the CD11c and CD86 phenotype of DC cells in Example 2;

[0120] Figure 5 In the figure, picture a is the flow cytometric graph of the CD14 phenotype of DC precursor cells in Example 3, and picture b is the flow cytometric graph of the CD11c and CD86 phenotype of DC cells in Example 3;

[0121] Figure 6 In the figure, picture a is the flow cytometric graph of the CD14 phenotype of DC precursor cells in Example 4, and picture b is the flow cytometric graph of the CD11c and CD86 phenotype of DC cells in Example 4.

[0122] Depend on Figures 3 to 6 It can be seen that the markers CD11c and CD86 represent the expression levels of mature DC cells, respectively. In Examples 1 to 4, the proportions of DC precursor cell marker CD14 are 90.08%, 94.42%, 94.42% and 91.71%, respectively; the proportions of mature DC cell markers CD11c and CD86 are 92.31%, 95.95%, 93.72% and 65.56%, respectively; this shows that in Examples 1 to 4, the proportions of immature DC cells are basically the same, but the proportion of induced mature DC cells in Examples 1 to 3 (greater than 90%) is significantly higher than the proportion of mature DC cells in Example 4 (65.56%); this is because: in Examples 1 to 3 of the present invention, FL-3t, TPO and other components are added from 7 days; among them, the FL-3t component can regulate the transformation of immature DC cells into mature DC cells, and the TPO component further stimulates and promotes the rapid maturation of DC cells.

[0123] 3. DC cell expansion and growth test

[0124] The DC cells cultured in Examples 1 to 4 were sampled on the 1st day, the 3rd day, the 5th day, the 7th day, and the 9th day. A cell counting instrument was used to perform cell counting detection. The detection results are shown in Tables 1 and Figure 7 As shown; among them, Figure 7 It is a curve graph drawn corresponding to the data in Table 1.

[0125] Table 1 Statistics of mature DC cell numbers

[0126]

[0127] From Table 1 and Figure 7 It can be seen that after the 7th day, the DC cells in Examples 1 to 4 grow rapidly, but the number of DC cells in Examples 1 to 3 that proliferate far exceeds the number of DC cells in Example 4; that is, the expansion times of DC cells in Examples 1 to 3 are 173.49, 166.48, and 156.22 times, respectively, compared with the 1st day of cell culture to the 9th day, and the expansion times of DC cells in Example 4 is 81.52 times. This is because, starting from the 7th day, FL-3t, TPO, phospholipids and inorganic salt components are added to the DC cell culture fluid in Examples 1 to 3, and the FL-3t component has the function of regulating and transforming immature DC cells into mature DC cells; the TPO component has the function of further stimulating and promoting the rapid maturation of DC cells; the phospholipid component can effectively promote the growth of DC cells; the inorganic salt balanced solution can use its anion and cation ion buffering effect to maintain the pH range required for cell physiology, so as to maintain the intracellular and extracellular osmotic pressure of cells during cell growth, ensure the rapid growth of cells, and shorten the culture time of DC cells to 9 days.

[0128] 4. Antigen-specific detection test of DC cells

[0129] The DC cells in Examples 1 to 4 were cultured for 9 days and samples were taken. The mature DC cells obtained by sampling were co-cultured with T cells at a cell number ratio of 1:10 for 5 days. The proliferation of T cells was detected by CCK method. The detection results are shown in Table 2.

[0130] Table 2 Effect of mature DC cells on T cell proliferation

[0131] Example T cell proliferation rate (%) Example 1 368.95 Example 2 375.61 Example 3 366.29 Example 4 124.56

[0132] As shown in Table 2, the T cell proliferation ratios in Examples 1 to 3 are much higher than that in Example 4 (Comparative Example 1); this is because DC cells, as antigen presenting cells, can stimulate T cell proliferation. The combined induction of components such as FL-3t, TPO, phospholipids, and inorganic salts in the DC cell culture fluid provided by the present invention can further improve the yield, maturity, migration ability, and immune activation ability of DC cells, promote DC cell maturation, and induce high expression of surface chemokine receptors of mature DC.

[0133] It should be understood that the above description of the preferred embodiments of the present invention is relatively detailed and cannot be regarded as limiting the scope of patent protection of the present invention. The scope of patent protection of the present invention shall be based on the attached claims.

Claims

1. A DC cell culture medium, comprising a lymphocyte serum-free culture medium, wherein the culture medium comprises component A and component B; wherein: Component A contains GM-CSF with a final concentration of 20-200 ng / ml, rhIL-4 with a final concentration of 20-100 ng / ml and autologous serum with a final concentration of 1-10% (v / v); Component B contains TNF-α with a final concentration of 5-20 ng / ml, lipopolysaccharide with a final concentration of 0.1-10 μg / ml, IL-6 with a final concentration of 50-200 ng / ml and PGE2 with a final concentration of 1-200 μg / ml; characterized in that the culture solution also includes component C, which contains FL-3t with a final concentration of 10-130 ng / ml, TPO with a final concentration of 1-80 ng / ml, phospholipids with a final concentration of 0.5-5 μg / ml and inorganic salts with a final concentration of 1-10 mg / ml.

2. The DC cell culture medium according to claim 1, characterized in that In the culture medium: component A contains GM-CSF with a final concentration of 50 ng / ml, rhIL-4 with a final concentration of 50 ng / ml and autologous serum with a final concentration of 5% (v / v); component B contains TNF-α with a final concentration of 10 ng / ml, lipopolysaccharide with a final concentration of 5 μg / ml, IL-6 with a final concentration of 100 ng / ml and PGE2 with a final concentration of 100 μg / ml; component C contains FL-3t with a final concentration of 50 ng / ml, TPO with a final concentration of 20 ng / ml, phospholipid with a final concentration of 2 μg / ml and inorganic salt with a final concentration of 3 mg / ml.

3. The DC cell culture medium according to claim 1 or 2, characterized in that The lymphocyte serum-free culture medium is GT-T551 H3, DMEM or RPMI-1640.

4. The DC cell culture medium according to claim 1 or 2, characterized in that The phospholipid is phosphatidic acid or lysophosphatidic acid.

5. The DC cell culture medium according to claim 1 or 2, characterized in that: The inorganic salt includes one or more of sodium phosphate, potassium phosphate, calcium phosphate, magnesium phosphate, sodium chloride, potassium chloride, calcium chloride, magnesium chloride, sodium bicarbonate, potassium bicarbonate, calcium bicarbonate, and magnesium bicarbonate.

6. A method for culturing DC cells, characterized in that: The steps include: On day 0, first, the mononuclear cells are added to a culture bottle containing the lymphocyte serum-free culture medium according to claim 1, and statically cultured in an incubator at 37° C. and 5% (v / v) CO2 for 2 h to 5 h; then, the cell culture waste liquid and suspended cells in the culture bottle are removed, and the culture medium containing component A according to claim 1 is supplemented, and static culture is continued in an incubator at 37° C. and 5% CO2; On the third day, the cell culture waste liquid and suspended cells in the culture flask were removed, and the culture liquid containing component A according to claim 1 was fully supplemented into the culture flask, and static culture was carried out in an incubator at 37° C. and 5% (v / v) CO 2 ; On the fifth day, the cell culture waste liquid and suspended cells in the culture flask were removed, and the culture liquid containing component B according to claim 1 was fully supplemented into the culture flask, and static culture was carried out in an incubator at 37° C. and 5% (v / v) CO 2 ; On the 7th day, the cell culture waste liquid in the culture flask is removed, the cells in the culture flask are transferred to a culture bag, and the culture liquid containing component C according to claim 1 is fully added to the culture bag, and the culture is statically cultured in an incubator at 37° C. and 5% (v / v) CO2; On day 9, the cell culture waste liquid was removed, the cells were collected and centrifuged at 300-800g for 5-10 min; the supernatant was removed, and the cell pellet was washed with PBS to obtain DC cells.

7. The method for culturing DC cells according to claim 6, characterized in that: When the culture medium containing component C is added on the 7th day, the pH value of the cell culture medium in the culture bag should be controlled at 7.2-7.

6.

8. The method for culturing DC cells according to claim 6, characterized in that: When the culture solution containing component C is added on the 7th day, if component C contains sodium bicarbonate, potassium bicarbonate, calcium bicarbonate, and magnesium bicarbonate, the culture environment in the incubator should be 36°C and 6% (v / v) CO2 on the 7th day.